A vaccine that could cure diabetes to be tested at MGH against coronavirus
A generic vaccine that's shown promise in reversing type 1 diabetes long-term in trials at Massachusetts General Hospital will soon have a new target: the COVID-19 coronavirus.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Jessica Bartlett Source Type: news
More News: Biotechnology | Coronavirus | COVID-19 | Diabetes | Diabetes Type 1 | Endocrinology | Health Management | Hospitals | Vaccines